These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 15288243

  • 1. Integrating virtual screening in lead discovery.
    Oprea TI, Matter H.
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B.
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y.
    J Chem Inf Model; 2005 Mar; 45(4):1082-100. PubMed ID: 16045304
    [Abstract] [Full Text] [Related]

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 9. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC.
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
    Kalliokoski T, Salo HS, Lahtela-Kakkonen M, Poso A.
    J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C.
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [Abstract] [Full Text] [Related]

  • 14. Computer-aided design of chiral ligands. Part III. A novel ligand for asymmetric allylation designed using computational techniques.
    Kozlowski MC, Waters SP, Skudlarek JW, Evans CA.
    Org Lett; 2002 Dec 12; 4(25):4391-3. PubMed ID: 12465895
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structure-based drug metabolism predictions for drug design.
    Sun H, Scott DO.
    Chem Biol Drug Des; 2010 Jan 12; 75(1):3-17. PubMed ID: 19878193
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure-based approaches to drug design and virtual screening.
    Waszkowycz B.
    Curr Opin Drug Discov Devel; 2002 May 12; 5(3):407-13. PubMed ID: 12058616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.